clinical trials for glp-1 obesity meds actively recruiting Receptor Agonists Weight Control: Emerging Insights from and Future Perspectives 📣 NOW RECRUITING: New Clinical

While these drugs have demonstrated clinical efficacy, recent data from regulatory agencies and medical reports have raised serious concerns about adverse reactionsincluding reported ozempic deaths

CJC-1295, an analog of GHRH (Growth Hormone-Releasing Hormone), stimulates the release of growth hormone in a pulsatile fashion and elevates IGF-1 levels [1]

Nanoparticles and Immunotherapy The synergism between ferroptosis and immunomodulation in cancer has been widely investigated in recent decades

Oral versions of GLP-1s have also been approved, though they thus far have lower efficacy

The Indian GLP-1 market could expand fivefold, from an estimated Rs 1,0001,200 crore in 2025 to Rs 4,5005,000 crore by 2030

Communications Medicine , 4, 137 (2024), DOI: 10.1038/s43856-024-00566-z, Written by Dr